文献速递流行病学与生物统计临床试验与 GCP

设计考虑随机治疗时间滞后效应的癌症免疫治疗试验

Designing cancer immunotherapy trials with random treatment time-lag effect.
PubMed 文献 · Stat Med · 2018-09-10

本文提出广义分段加权对数秩检验(GPW-Logrank)以处理癌症免疫治疗试验中个体滞后期随机变化的滞后效应,并开发解析与数值方法用于样本量和功效计算;模拟显示当滞后随机时该方法较忽略滞后标准做法更高效,较Xu等固定滞后方法在模型误设时更稳健,并发布R包DelayedEffect.Design。

要点

  • GPW-Logrank检验可处理随机时间滞后效应并最大化研究功效。
  • 提供解析与数值方法用于样本量和功效计算。
  • 随机滞后时较忽略滞后方法更高效,较固定滞后方法更稳健。

核心结论

  • 所提出的设计与分析程序在预期随机滞后时较忽略延迟效应的标准做法显著更高效。
  • 与Xu等考虑固定时间滞后效应的方法相比,所提方法在滞后模型误设时显著更稳健。

研究设计与样本

  • 提出广义分段加权对数秩(GPW-Logrank)检验,并基于该检验开发解析与数值方法用于样本量和功效计算。
  • 推导渐近性质并通过模拟评估有限样本效率。

主要发现

  • 当预期随机滞后时,所提设计与分析程序较忽略延迟效应的标准做法显著更高效。
  • 与Xu等考虑固定时间滞后效应的方法相比,所提方法在滞后模型误设时显著更稳健。

临床怎么用

  • 在癌症免疫治疗试验设计中,若预期存在个体间随机变化的滞后效应,可采用GPW-Logrank检验进行样本量与功效计算。
  • 实际实施可使用R包DelayedEffect.Design。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In some clinical settings such as the cancer immunotherapy trials, a treatment time-lag effect may be present and the lag duration possibly vary from subject to subject. An efficient study design and analysis procedure should not only take into account the time-lag effect but also consider the individual heterogeneity in the lag duration. In this paper, we present a Generalized Piecewise Weighted Logrank (GPW-Logrank) test, designed to account for the random time-lag effect while maximizing the study power with respect to the weights. Based on the proposed test, both analytic and numeric approaches are developed for the sample size and power calculation. Asymptotic properties are derived and finite sample efficiency is evaluated in simulations. Compared with the standard practice ignoring the delayed effect, the proposed design and analysis procedures are substantially more efficient when a random lag is expected; further, compared with the existing methods by Xu et al considering the fixed time-lag effect, the proposed approaches are significantly more robust when the lag model is misspecified. An R package (DelayedEffect.Design) is developed for implementation.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Xu Z, Park Y, Zhen B, et al. Designing cancer immunotherapy trials with random treatment time-lag effect. Stat Med. 2018. PMID: 30203592. doi:10.1002/sim.7937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。